arGEN-X SE ADR (ARGX): Price and Financial Metrics
ARGX Price/Volume Stats
Current price | $593.95 | 52-week high | $611.22 |
Prev. close | $588.94 | 52-week low | $327.73 |
Day low | $586.59 | Volume | 215,270 |
Day high | $601.19 | Avg. volume | 306,634 |
50-day MA | $550.08 | Dividend yield | N/A |
200-day MA | $450.86 | Market Cap | 35.52B |
ARGX Stock Price Chart Interactive Chart >
arGEN-X SE ADR (ARGX) Company Bio
argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancers, today announced its 2021 corporate priorities and highlighted recent achievements from its late-stage immunology pipeline driven by its FcRn antagonist, efgartigimod. Additionally, the Company announced interim data from the Phase 2 CULMINATE trial of cusatuzumab in development with Cilag GmbH International, an affiliate of Janssen, and provided financial guidance for 2021. (Source:Wiki)
ARGX Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | N/A |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Continue Researching ARGX
Want to do more research on Argenx Se's stock and its price? Try the links below:Argenx Se (ARGX) Stock Price | Nasdaq
Argenx Se (ARGX) Stock Quote, History and News - Yahoo Finance
Argenx Se (ARGX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...